Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Airey

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Studies in Health Technology and Informatics|October 6, 2007
Generation Y in healthcare: the need for new socio-technical consideration for future technology design in healthcareErin Mills, Caroline Airey, Kwang Chien Yee
Studies in Health Technology and Informatics|May 20, 2008
Perfect match? Generation Y as change agents for information communication technology implementation in healthcareKwang Chien Yee, Erin Miils, Caroline Airey
Parkinsonism & Related Disorders|July 24, 2012
NeuroferritinopathyAlexander Lehn, Richard Boyle, Helen Brown, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 22, 2016
iPad colour vision apps for dyschromatopsia screeningThomas Gordon Campbell, Alexander Lehn, Stefan Blum, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 11, 2016
A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN)Janet M Schloss, Maree Colosimo, Caroline Airey, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 8, 2013
Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic reviewJanet M Schloss, Maree Colosimo, Caroline Airey, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 26, 2013
Susac syndrome and multifocal motor neuropathy first manifesting in pregnancyZara A Ioannides, Caroline Airey, Narelle Fagermo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2018
A case of immune-mediated encephalitis related to daclizumab therapyMichael Devlin, Andrew Swayne, Martin Newman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Studies in Health Technology and Informatics|October 6, 2007
Generation Y in healthcare: the need for new socio-technical consideration for future technology design in healthcareErin Mills, Caroline Airey, Kwang Chien Yee
Studies in Health Technology and Informatics|May 20, 2008
Perfect match? Generation Y as change agents for information communication technology implementation in healthcareKwang Chien Yee, Erin Miils, Caroline Airey
Parkinsonism & Related Disorders|July 24, 2012
NeuroferritinopathyAlexander Lehn, Richard Boyle, Helen Brown, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 22, 2016
iPad colour vision apps for dyschromatopsia screeningThomas Gordon Campbell, Alexander Lehn, Stefan Blum, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 11, 2016
A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN)Janet M Schloss, Maree Colosimo, Caroline Airey, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 8, 2013
Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic reviewJanet M Schloss, Maree Colosimo, Caroline Airey, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 26, 2013
Susac syndrome and multifocal motor neuropathy first manifesting in pregnancyZara A Ioannides, Caroline Airey, Narelle Fagermo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2018
A case of immune-mediated encephalitis related to daclizumab therapyMichael Devlin, Andrew Swayne, Martin Newman, et al.
Pageof 1